TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · major macro event coming up
DMAC

DiaMedica Therapeutics Inc

Healthcare · Biotechnology

10.00$ +7.6% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns DiaMedica Therapeutics Inc (DMAC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 46.9% of the shares are freely tradable; institutional investors hold 37.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 37.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 27.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 46.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 15.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 54Mio.

Largest Shareholders

Institutions

Institutions DMAC
Name Stake (%) Shares Change (%) Date
Cooperman Leon G 6.40 3,450,000 +70.8 06/30/2026
BlackRock Inc 4.18 2,252,285 +21.3 06/30/2026
Geode Capital Management, LLC 1.66 894,115 +14.6 06/30/2026
PARAGON Assoc & PARAGON Assoc II JV 1.62 875,000 +0.0 03/31/2026
Millennium Management LLC 1.57 845,309 -9.6 06/30/2026
State Street Corp 1.20 646,743 +0.4 06/30/2026
Bleichroeder LP 0.71 382,317 +0.0 06/30/2026
Vanguard Capital Management, LLC 0.66 355,523 +6.6 06/30/2026

Funds

Funds DMAC
Name Stake (%) Shares Change (%) Date
iShares Russell 2000 ETF 1.74 938,051 -1.1 09/30/2026
Fidelity Small Cap Index 0.74 399,641 +0.3 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings DMAC
Person Role Shares Value As of Type
Pauls Dietrich John President & CEO 128,791 1,287,910 $ Aug 10, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 10, 2026 Pauls Dietrich John President & CEO Other 60,200 0.00 –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?